跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
特罗凯 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Erlotinib Hydrochloride Tablets
Approved
化学药品
Erlotinib Hydrochloride Tablets
Roche Registration GmbH
🇨🇳 National Medical Products Administration
Approval Date
Nov 17, 2020
Approval ID
8884YmkEhtF
Company
Roche Registration GmbH
Type
化学药品
Approval Details
Approval Id
8884YmkEhtF
Approval Number
国药准字HJ20160395
Generic Name
盐酸厄洛替尼片
Generic Name En
Erlotinib Hydrochloride Tablets
Trade Name
特罗凯
Drug Type
化学药品
Dosage Form
片剂
Strength
150mg
Reg Date
2020-11-17
Expired Date
2025-11-16
Company Name
Roche Registration GmbH
Production Company Name
DELPHARM MILANO SRL
Company Detail Path
/organization/roche-registration-gmbh
Production Company Detail Path
/organization/delpharm-milano-srl
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 17, 2020
Approval ID
8884YmkEhtF
Type
化学药品
Back to NMPA Approvals